MXPA03006089A - Dispersion en fase solida de acidos quinolona-o nafthidronacarboxilicos. - Google Patents

Dispersion en fase solida de acidos quinolona-o nafthidronacarboxilicos.

Info

Publication number
MXPA03006089A
MXPA03006089A MXPA03006089A MXPA03006089A MXPA03006089A MX PA03006089 A MXPA03006089 A MX PA03006089A MX PA03006089 A MXPA03006089 A MX PA03006089A MX PA03006089 A MXPA03006089 A MX PA03006089A MX PA03006089 A MXPA03006089 A MX PA03006089A
Authority
MX
Mexico
Prior art keywords
acid
quinolone
naphthidronacarboxylic
dispersion
insoluble matrix
Prior art date
Application number
MXPA03006089A
Other languages
English (en)
Spanish (es)
Inventor
A Cabrera Francisco
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of MXPA03006089A publication Critical patent/MXPA03006089A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
MXPA03006089A 2001-01-24 2002-01-18 Dispersion en fase solida de acidos quinolona-o nafthidronacarboxilicos. MXPA03006089A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/768,657 US20020122824A1 (en) 2001-01-24 2001-01-24 Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
PCT/US2002/001895 WO2002058669A1 (fr) 2001-01-24 2002-01-18 Dispersion en phase solide d'acides quinolonecarboxyliques ou naphtyridonecarboxyliques

Publications (1)

Publication Number Publication Date
MXPA03006089A true MXPA03006089A (es) 2005-07-01

Family

ID=25083122

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006089A MXPA03006089A (es) 2001-01-24 2002-01-18 Dispersion en fase solida de acidos quinolona-o nafthidronacarboxilicos.

Country Status (6)

Country Link
US (2) US20020122824A1 (fr)
EP (1) EP1355629B1 (fr)
CA (1) CA2435414C (fr)
DE (1) DE60229106D1 (fr)
MX (1) MXPA03006089A (fr)
WO (1) WO2002058669A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
WO2008064259A2 (fr) * 2006-11-21 2008-05-29 Biokey, Inc. Composition de dispersion solide
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
WO2010034853A1 (fr) 2008-09-23 2010-04-01 Laboratorio Jaer, S.A. Utilisation de xylitol ou de ses dérivés pour le masquage du goût d'agents chimiothérapeutiques du groupe de l'acide quinolon-o-naphthyridoncarboxilique administrés dans des aliments destinés au bétail porcin
EP2332916A3 (fr) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto Procede de la preparation du marbofloxacin et produits intermediares
WO2018129079A1 (fr) * 2017-01-03 2018-07-12 Thermolife International, Llc Procédé pour isoler de la théacrine et composition comprenant de la théacrine
CN111700874A (zh) * 2020-06-03 2020-09-25 华中农业大学 一种恩诺沙星肠溶速释掩味颗粒剂及其制备方法
CN111529499B (zh) * 2020-06-11 2021-09-17 华中农业大学 一种兽用恩诺沙星风味片剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3517535A1 (de) * 1985-05-15 1986-11-20 Bayer Ag, 5090 Leverkusen 1-aryl-4-chinolon-3-carbonsaeuren
US5281596A (en) * 1986-02-19 1994-01-25 Bayer Aktiengesellschaft Antibacterial drugs for fish
DE3719764A1 (de) 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP2949448B2 (ja) * 1992-11-30 1999-09-13 ケーヴィ ファーマセチカル カンパニー 味を隠された医薬材料
JPH06175452A (ja) * 1992-12-11 1994-06-24 Matsushita Electric Ind Co Ltd 電子写真装置
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
JP3143433B2 (ja) * 1998-07-07 2001-03-07 三基商事株式会社 マスキング組成物

Also Published As

Publication number Publication date
EP1355629B1 (fr) 2008-10-01
CA2435414C (fr) 2010-11-23
US20040204442A1 (en) 2004-10-14
EP1355629A1 (fr) 2003-10-29
CA2435414A1 (fr) 2002-08-01
DE60229106D1 (de) 2008-11-13
WO2002058669A1 (fr) 2002-08-01
US7112336B2 (en) 2006-09-26
US20020122824A1 (en) 2002-09-05

Similar Documents

Publication Publication Date Title
CA2263584C (fr) Formulations d'acides dicarboxyliques de quinolone ou de naphtyridone pouvant etre administrees par voie orale
CA1273579A (fr) Produits bactericides pour l'emploi en medecine veterinaire
AU2008258887B2 (en) Improved taste-masking extrudates
US7112336B2 (en) Solid phase dispersion of quinolone or naphthyridonecarboxylic acids
NO338438B1 (no) Tabletter inneholdende enrofloksacin og smaks- og/eller aromastoffer og fremgangsmåte for fremstilling derav.
KR940002823B1 (ko) 퀴놀론카복실산 또는 이의 유도체의 엠보네이트의 제조방법
JPH04169585A (ja) （Ｓ）―１０―（１―アミノシクロプロピル）―９―フルオロ―３―メチル―７―オキソ―２，３―ジヒドロ―７Ｈ―ピリド［１，２，３―ｄｅ］［１，４］ベンゾオキサジン―６―カルボン酸の製剤化方法

Legal Events

Date Code Title Description
FG Grant or registration